Healthcare RevOps is a $340M segment growing at 23% annually. Three players hold 67% market share. The remaining 33% is fragmented across point solutions and custom builds. That fragmentation is our opportunity.
Competitor 1: MedStack RevOps. $89M ARR. Largest player. Legacy architecture built in 2019. Their platform handles compliance well but integration is manual. Eight-step process to connect a new tool. Customer reviews mention "reliable but rigid." Their NPS dropped 12 points in the last quarter. Vulnerability: they can't innovate fast enough. Their compliance layer is hardcoded, not configurable. Every regulatory update requires a platform update. Customers are waiting for them to modernize. Some are tired of waiting.
Competitor 2: HealthFlow. $54M ARR. Cloud-native but narrow. Strong on pipeline management, weak on data consolidation. They don't offer attribution modeling. Their customers use third-party tools for analytics — which creates the exact tool fragmentation problem our positioning addresses. Vulnerability: they solve half the problem. We solve the whole problem.
Competitor 3: Nextera Health Systems. $118M ARR. The formidable one. Modern architecture. Strong compliance. Good integration capabilities. Well-funded (Series D, $200M). Their weakness is subtle: they're enterprise-only. Minimum deal size $200K. Our ICP — $10M-$50M companies — is below their floor. They literally don't compete for our prospects. The segment we're entering has one strong competitor (MedStack) and one half-solution (HealthFlow). Favorable dynamics.
The intelligence package sent to HUNTER includes: competitor pricing (confirmed through job postings and customer interviews), integration capabilities (documented from their public APIs and help centers), and customer sentiment (aggregated from review platforms and community forums).
The signal is clear. The vertical is ready. The competitors are mapped.
Transmission timestamp: 03:47:19